BioAtla (BCAB) Equity Ratio (2020 - 2025)
BioAtla's Equity Ratio history spans 6 years, with the latest figure at 2.62 for Q4 2025.
- For Q4 2025, Equity Ratio fell 1061.74% year-over-year to 2.62; the TTM value through Dec 2025 reached 2.62, down 1061.74%, while the annual FY2025 figure was 2.62, 1061.74% down from the prior year.
- Equity Ratio reached 2.62 in Q4 2025 per BCAB's latest filing, down from 1.96 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.86 in Q1 2021 to a low of 2.62 in Q4 2025.
- Average Equity Ratio over 5 years is 0.28, with a median of 0.66 recorded in 2023.
- Peak YoY movement for Equity Ratio: fell 3.34% in 2021, then tumbled 1061.74% in 2025.
- A 5-year view of Equity Ratio shows it stood at 0.83 in 2021, then fell by 3.59% to 0.8 in 2022, then decreased by 26.07% to 0.59 in 2023, then crashed by 53.93% to 0.27 in 2024, then crashed by 1061.74% to 2.62 in 2025.
- Per Business Quant, the three most recent readings for BCAB's Equity Ratio are 2.62 (Q4 2025), 1.96 (Q3 2025), and 0.62 (Q2 2025).